Chien Jeremy, He Xiaoping, Shridhar Viji
Department of Experimental Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
J Cell Biochem. 2009 May 15;107(2):253-63. doi: 10.1002/jcb.22121.
Serine protease HtrA1 belongs to a family of chymotrypsin-like proteases that were first identified in bacteria and later in mammalian systems. These proteases were identified as components of protein quality control in prokaryotic systems and as regulators of diverse signaling pathways in mammalian systems. In particular, HtrA1 is implicated in trophoblast cell migration and invasion, tumor progression, chemotherapy-induced cytotoxicity, osteoarthritis, age-related macular degeneration, and pathogenesis of Alzheimer's disease. However, systematic analysis of its potential substrates in biological system is still lacking. Therefore, we performed a mixture-based oriented peptide library screening to identify putative substrates of HtrA1. We identified [AEGR]-[LAGR]-[IAMLR]-[TVIAL] as consensus residues for P1 to P4 sites. We identified several putative substrates of HtrA1 involved in the pathogenesis of various diseases. In this study, we report on the identification of tubulins as potential substrates of HtrA1, and validated tubulins as in vitro and intracellular substrates of HtrA1. These results provide initial insights into substrate identification and functional characterization of HtrA1 in pathogenesis of various diseases.
丝氨酸蛋白酶HtrA1属于一类类胰凝乳蛋白酶家族,这类蛋白酶最初在细菌中被发现,后来在哺乳动物系统中也被发现。这些蛋白酶在原核系统中被鉴定为蛋白质质量控制的组成部分,在哺乳动物系统中则是多种信号通路的调节因子。特别是,HtrA1与滋养层细胞迁移和侵袭、肿瘤进展、化疗诱导的细胞毒性、骨关节炎、年龄相关性黄斑变性以及阿尔茨海默病的发病机制有关。然而,对其在生物系统中潜在底物的系统分析仍然缺乏。因此,我们进行了基于混合物的定向肽库筛选,以鉴定HtrA1的推定底物。我们确定了[AEGR]-[LAGR]-[IAMLR]-[TVIAL]作为P1至P4位点的共有残基。我们鉴定了几种参与各种疾病发病机制的HtrA1推定底物。在本研究中,我们报告了微管蛋白作为HtrA1潜在底物的鉴定,并验证了微管蛋白作为HtrA1的体外和细胞内底物。这些结果为HtrA1在各种疾病发病机制中的底物鉴定和功能表征提供了初步见解。